[Asia Economy Reporter Lim Hye-sun] The Korea Exchange KOSDAQ Market Headquarters announced regarding Solgo Bio, "On the 19th, it was disclosed that the auditor's opinion on the recent semi-annual financial statements was a disclaimer of opinion," adding, "This constitutes grounds for delisting under Article 38 of the KOSDAQ Market Listing Regulations. In this regard, the company may file an objection within 7 business days (by the 28th) from the date it received the delisting notification. If no objection is filed, the delisting process will proceed."



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing